Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
![[Pro3]-GIP (Mouse) acetate](https://img.aobious.com/img/p/5/7/0/6/2/57062-large_default.webp "[Pro3]-GIP (Mouse) acetate")
![[Pro3]-GIP (Mouse) acetate](https://img.aobious.com/img/p/5/7/0/6/2/57062.jpg "[Pro3]-GIP (Mouse) acetate")
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $108.80 | Total: $544.00 |
| 1 | 10 | $92.16 | Total: $921.60 |
| 1 | 25 | $78.08 | Total: $1,952.00 |
| 1 | 50 | $66.56 | Total: $3,328.00 |
| 1 | 100 | $57.60 | Total: $5,760.00 |
Overview
[Pro3]-GIP (Mouse) acetate is mouse [Pro3]-GIP. [Pro3]-GIP is a GIP receptor antagonist.
Chemical Properties
| Molecular Formula | C227H346N62O66S |
| Molecular Weight | 5028.53 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC[C@@H]([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H]1CCCN1C([C@@H](NC([C@@H](N)CC2=CC=C(O)C=C2)=O)C)=O)=O)=O)[C@H](O)C)=O)CC3=CC=CC=C3)=O)[C@H](CC)C)=O)CO)=O)CC(O)=O)=O)CC4=CC=C(O)C=C4)=O)CO)=O)[C@H](CC)C)=O)C)=O)CCSC)=O)CC(O)=O)=O)CCCCN)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CCC(N)=O)=O)[C@H](O)C)=O)[C@H](CC)C)=O)CC(N)=O)=O)CC5=CNC=N5)=O)CCCCN)=O)CC6=CNC7=CC=CC=C76)=O)CC(O)=O)=O)CO)=O)CCCCN)=O)CCCCN)=O)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)C)=O)CC(C)C)=O)CC(C)C)=O)CC8=CNC9=CC=CC=C98)=O)CC(N)=O)=O)C(C)C)=O)CC%10=CC=CC=C%10)=O)CC(O)=O)=O)CCC(N)=O)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)C.CC(O)=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Irwin N, et al. Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist [Pro3]GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in obob mice. Diabetologia. 2007 Jul;50[7] 1532-40.